Oncology Institute, Inc. financial data

Symbol
TOI, TOIIW on Nasdaq, DFPH on OTC
Location
Cerritos, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 13 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 179% % -44%
Quick Ratio 24% % -18%
Debt-to-equity -5339% % -1313%
Return On Equity 2104% %
Return On Assets -40% % -10%
Operating Margin -8.9% % 47%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 98,381,340 shares 30%
Common Stock, Shares, Outstanding 97,569,737 shares 29%
Entity Public Float $34,900,000 USD -16%
Common Stock, Value, Issued $10,000 USD 25%
Weighted Average Number of Shares Outstanding, Basic 97,474,797 shares 29%
Weighted Average Number of Shares Outstanding, Diluted 97,474,797 shares 29%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $461,039,000 USD 22%
Operating Income (Loss) $41,105,000 USD 35%
Nonoperating Income (Expense) $25,306,000 USD -258%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $66,411,000 USD 5.9%
Income Tax Expense (Benefit) $131,000 USD 58%
Net Income (Loss) Attributable to Parent $66,280,000 USD 5.6%
Earnings Per Share, Basic 0 USD/shares 18%
Earnings Per Share, Diluted 0 USD/shares 18%

Balance Sheet

Label TTM Value / Value Unit Change %
Marketable Securities, Current $0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current $59,639,000 USD 9.4%
Inventory, Net $18,882,000 USD 87%
Assets, Current $110,092,000 USD -5.4%
Property, Plant and Equipment, Net $10,714,000 USD -13%
Operating Lease, Right-of-Use Asset $23,265,000 USD -14%
Intangible Assets, Net (Excluding Goodwill) $11,732,000 USD -25%
Goodwill $7,230,000 USD 0%
Other Assets, Noncurrent $586,000 USD -0.34%
Assets $163,619,000 USD -8.7%
Accounts Payable, Current $35,634,000 USD 45%
Employee-related Liabilities, Current $8,003,000 USD 9.6%
Accrued Liabilities, Current $22,785,000 USD 48%
Contract with Customer, Liability, Current $4,900,000 USD 255%
Liabilities, Current $65,580,000 USD 40%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $20,195,000 USD -18%
Other Liabilities, Noncurrent $3,000 USD -98%
Liabilities $175,893,000 USD 7.4%
Retained Earnings (Accumulated Deficit) $263,911,000 USD -34%
Stockholders' Equity Attributable to Parent $12,274,000 USD -179%
Liabilities and Equity $163,619,000 USD -8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $4,988,000 USD 69%
Net Cash Provided by (Used in) Financing Activities $4,740,000 USD -405%
Net Cash Provided by (Used in) Investing Activities $202,000 USD -101%
Common Stock, Shares Authorized 500,000,000 shares 0%
Common Stock, Shares, Issued 99,303,511 shares 28%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27,658,000 USD -42%
Interest Paid, Excluding Capitalized Interest, Operating Activities $1,290,000 USD 14%
Deferred Tax Assets, Valuation Allowance $63,595,000 USD 18%
Deferred Tax Assets, Gross $72,783,000 USD 13%
Operating Lease, Liability $27,356,000 USD -13%
Depreciation $3,981,000 USD 30%
Payments to Acquire Property, Plant, and Equipment $328,000 USD -46%
Lessee, Operating Lease, Liability, to be Paid $31,667,000 USD -15%
Operating Lease, Liability, Current $7,161,000 USD 6.1%
Lessee, Operating Lease, Liability, to be Paid, Year Two $7,472,000 USD -6.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $8,592,000 USD 1.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $4,311,000 USD -23%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,565,000 USD -18%
Deferred Tax Assets, Operating Loss Carryforwards $53,419,000 USD 32%
Preferred Stock, Shares Issued 193,507 shares 17%
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $99,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,912,000 USD -18%
Operating Lease, Payments $2,205,000 USD 8%
Additional Paid in Capital $252,646,000 USD 18%
Preferred Stock, Shares Outstanding 193,507 shares 17%
Amortization of Intangible Assets $3,036,000 USD -1.7%
Depreciation, Depletion and Amortization $1,784,000 USD 20%
Deferred Tax Assets, Net of Valuation Allowance $9,188,000 USD -9.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%